Clustering data with hclust algorithm for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine (Study ST000917)

Core E Neutral Lipids (Analysis AN001500)
MetaboliteStructureF1F2F3F4
1,2-DG(36:4)ME232130NA0.110.066.61
TG(54:0)ME2320710.560.150.126.65
1,2-DG(38:2)ME232145NANA0.492.52
TG(55:4)ME232074NA0.290.342.37
TG(57:5)ME232087NA0.210.192.61
TG(55:3)ME232075NA0.890.622.83
TG(50:0)ME2320460.450.610.712.58
TG(54:3)ME2320680.380.740.812.67
1,2-DG(34:2)ME2321210.130.240.652.75
1,2-DG(36:2)ME2321320.140.330.742.65
TG(58:2)ME232097NA0.590.642.90
TG(52:4)ME2320540.250.510.662.78
TG(54:4)ME2320670.300.560.762.87
TG(52:0)ME2320580.310.290.324.20
TG(54:6)ME2320650.200.380.424.14
TG(57:4)ME232088NA0.380.283.06
1,2-DG(36:3)ME2321310.080.210.333.43
TG(54:5)ME2320660.280.420.523.60
TG(56:5)ME232080NA2.240.740.91
CE(18:3)ME2319770.912.020.760.55
CE(18:1)ME2319790.632.080.880.61
TG(56:6)ME2320790.592.150.880.79
TG(42:5)ME2319990.881.13NANA
TG(57:1)ME232091NA1.280.94NA
CE(22:5)ME231986NA1.450.85NA
TG(55:6)ME232072NA1.350.83NA
CE(16:1)ME231974NA0.801.20NA
TG(56:0)ME232085NA1.001.00NA
TG(60:2)ME232106NA0.941.06NA
TG(43:0)ME232007NA0.871.03NA
TG(60:1)ME232107NA0.911.03NA
TG(56:3)ME232082NA1.450.612.30
TG(56:4)ME232081NA1.540.611.79
1,2-DG(32:2)ME232114NANA1.820.18
1,2-DG(32:1)ME2321150.210.211.350.63
1,2-DG(33:0)ME232118NA0.301.410.53
1,2-DG(33:1)ME232117NA0.251.370.44
1,2-DG(35:1)ME232127NANA1.380.43
1,2-DG(35:2)ME232126NANA1.420.16
1,2-DG(30:0)ME2321100.290.411.460.85
1,2-DG(36:0)ME2321340.640.771.341.06
1,2-DG(34:0)ME2321230.500.721.690.84
1,2-DG(36:1)ME2321330.360.841.450.78
1,2-DG(32:0)ME2321160.380.611.910.60
1,2-DG(34:1)ME2321220.250.631.961.06
TG(51:5)ME232047NA0.79NA1.21
TG(60:4)ME232104NA0.80NA1.20
TG(43:2)ME232005NANA1.130.87
TG(53:0)ME232064NANA0.561.44
1,2-DG(34:3)ME232120NANA0.911.13
TG(48:4)ME232030NANA0.971.03
TG(57:2)ME232090NANA0.641.18
TG(40:1)ME231991NANA0.751.25
TG(51:0)ME232052NANA0.811.19
TG(54:1)ME2320700.361.070.971.59
TG(54:2)ME2320690.381.060.881.79
TG(48:0)ME2320340.480.710.931.62
TG(52:2)ME2320560.540.970.941.64
TG(50:1)ME2320450.530.941.101.46
TG(50:2)ME2320440.490.841.071.53
TG(52:1)ME2320570.530.871.041.56
TG(46:0)ME2320220.340.741.041.56
TG(51:1)ME2320510.280.811.061.43
TG(48:1)ME2320330.380.651.351.50
TG(46:2)ME2320200.260.641.201.60
TG(47:1)ME2320270.290.671.171.41
TG(49:1)ME2320390.360.681.211.15
TG(46:1)ME2320210.280.661.501.29
TG(48:2)ME2320320.360.641.351.27
TG(50:3)ME2320430.380.701.431.32
TG(52:3)ME2320550.370.820.802.22
TG(52:5)ME2320530.450.720.751.92
TG(57:3)ME232089NA0.530.422.05
TG(60:3)ME232105NA0.580.531.89
TG(58:4)ME232095NA0.990.621.38
TG(53:3)ME232061NA0.980.791.57
TG(55:2)ME232076NA0.860.781.54
1,2-DG(38:4)ME232143NA0.640.891.80
TG(58:3)ME232096NA0.880.711.83
CE(18:2)ME2319780.751.320.880.94
CE(20:4)ME2319810.431.201.110.76
TG(49:2)ME232038NA0.531.061.43
TG(51:2)ME232050NA0.640.961.50
TG(51:3)ME232049NA0.890.911.24
TG(53:2)ME232062NA0.860.891.35
1,2-DG(38:3)ME232144NA0.640.871.34
TG(51:4)ME232048NA0.560.971.27
TG(44:2)ME232011NA0.561.041.13
TG(42:0)ME232004NA0.751.051.11
TG(50:4)ME232042NA0.670.991.18
TG(53:1)ME232063NA0.720.961.26
TG(47:3)ME232025NA0.651.140.93
TG(53:4)ME232060NA0.671.200.87
TG(45:1)ME232015NA0.571.260.87
TG(46:3)ME232019NA0.541.180.96
TG(49:3)ME232037NA0.890.971.11
TG(42:1)ME232003NA0.771.090.94
TG(45:2)ME232014NA0.851.021.00
TG(43:1)ME232006NA0.911.140.80
TG(48:3)ME232031NA0.931.050.90
CE(22:6)ME231985NA1.081.050.79
TG(47:2)ME232026NA1.081.060.86
TG(49:0)ME232040NA1.020.991.01
TG(56:1)ME232084NA0.961.001.02
TG(44:1)ME232012NA1.041.020.95
TG(55:1)ME232077NA1.051.020.93
TG(44:0)ME232013NA1.121.020.91
TG(45:0)ME232016NA1.111.000.97
TG(58:1)ME232098NA1.181.030.65
CE(20:3)ME231982NA1.340.970.43
TG(58:6)ME232093NA1.461.010.51
TG(56:2)ME232083NA1.270.751.32
TG(47:0)ME232028NA1.340.961.03
CE(22:0)ME231989NA1.340.880.90
TG(58:5)ME232094NA1.340.821.02

Factors:

F1Diagnosis:Cirrhosis
F2Diagnosis:NASH
F3Diagnosis:Normal
F4Diagnosis:Steatosis
Data matrix
  logo